Early research (Phase 1)Study completedNCT04559126What this trial is testingEDP-297 in Healthy SubjectsWho this might be right forNASH - Nonalcoholic Steatohepatitis With Liver Fibrosis Enanta Pharmaceuticals, Inc 82
Testing effectiveness (Phase 2)Study completedNCT04173065What this trial is testingAssess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASHWho this might be right forNASH - Nonalcoholic Steatohepatitis Viking Therapeutics, Inc. 248
Large-scale testing (Phase 3)UnknownNCT05605158What this trial is testingComparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic SteatohepatitisWho this might be right forNon Alcoholic Steatohepatitis Tanta University 56
Large-scale testing (Phase 3)UnknownNCT02530138What this trial is testingThe Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty LiverWho this might be right forNon Alcoholic Steatohepatitis National Nutrition and Food Technology Institute 42
Testing effectiveness (Phase 2)Study completedNCT05327127What this trial is testingStudy to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver FibrosisWho this might be right forNASH Kowa Research Institute, Inc. 228
Testing effectiveness (Phase 2)Study completedNCT05809934What this trial is testingEvaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisWho this might be right forNonalcoholic Steatohepatitis AstraZeneca 220
Not applicableActive Not RecruitingNCT04595474What this trial is testingPrevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesWho this might be right forNonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, Liver+2 more Joslin Diabetes Center 533
Not applicableUnknownNCT03377140What this trial is testingThe Effects of Hesperidin on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver DiseaseWho this might be right forNon Alcoholic Steatohepatitis National Nutrition and Food Technology Institute 50
Testing effectiveness (Phase 2)Study completedNCT02217475What this trial is testingEfficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver FibrosisWho this might be right forNonalcoholic Steatohepatitis Tobira Therapeutics, Inc. 289
Testing effectiveness (Phase 2)Study completedNCT02854605What this trial is testingEvaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)Who this might be right forNonalcoholic Steatohepatitis (NASH) Gilead Sciences 140
Post-approval studies (Phase 4)Active Not RecruitingNCT05493761What this trial is testingEffect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver DiseaseWho this might be right forNonalcoholic Fatty LiverOsteoporosis, Postmenopausal Aristotle University Of Thessaloniki 72
Large-scale testing (Phase 3)Study completedNCT04197479What this trial is testingEvaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease PatientsWho this might be right forNon-Alcoholic Fatty Liver Disease Madrigal Pharmaceuticals, Inc. 1,343
Testing effectiveness (Phase 2)Study completedNCT03486899What this trial is testingExperimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver FibrosisWho this might be right forLiver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis Bristol-Myers Squibb 197
Early research (Phase 1)Study completedNCT04634149What this trial is testingEvaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver ImpairmentWho this might be right forModerate Liver ImpairmentSevere Liver Impairment Bristol-Myers Squibb 16
Testing effectiveness (Phase 2)Ended earlyNCT01672879What this trial is testingSimtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASHWho this might be right forLiver Fibrosis Due to NASH Gilead Sciences 259
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219What this trial is testingEvaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)Who this might be right forNon-Alcoholic Fatty Liver Disease Madrigal Pharmaceuticals, Inc. 810
Testing effectiveness (Phase 2)UnknownNCT05402371What this trial is testingEvaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisWho this might be right forNonalcoholic Steatohepatitis (NASH)Fibrosis, LiverNAFLD Hepion Pharmaceuticals, Inc. 120
Very early researchStudy completedNCT05737433What this trial is testingSingle Dose ADME Study of [14C]-Rencofilstat in Healthy Male SubjectsWho this might be right forNASH With Fibrosis Hepion Pharmaceuticals, Inc. 6
Post-approval studies (Phase 4)Looking for participantsNCT06523530What this trial is testingEffect of a GnRH Analog on Hepatic SteatosisWho this might be right forMetabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis Aristotle University Of Thessaloniki 62
Early research (Phase 1)Study completedNCT04643795What this trial is testingPhase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control SubjectsWho this might be right forHepatic ImpairmentNASH - Nonalcoholic SteatohepatitisCirrhosis, Liver Madrigal Pharmaceuticals, Inc. 87